Heparin induced thrombocytopenia Type II (HIT-II) is a dangerous thromboembolic complication of heparin therapy. The current literature on incidence and outcomes of HIT-II in aneurysmal subarachnoid hemorrhage (aSAH) patients remains sparse.
Objective
We report our institution's incidence and outcomes of HIT-II in aSAH patients.
Methods
We performed a retrospective cohort study at an academic medical center between June 2014 and July 2018. All patients had aSAH confirmed by digital subtraction angiography. Diagnosis of HIT-II was determined by positive results on both heparin PF4-platelet antibody ELISA (anti-PF4) and serotonin release assay (SRA).
Results
204 patients met inclusion criteria. Seven patients (7/204, 3.5%) underwent laboratory testing, three of whom met clinical criteria. HIT-II incidence was confirmed in two of these seven patients (2/204, 0.98%), who had high BMI and T4 scores.
Conclusion
Our institution's report of HIT-II incidence in aSAH patients is lower than previously reported in this population and more closely parallels HIT-II incidence in the general and surgical ICU setting. Widely-accepted American College of Chest Physicians (ACCP) clinical diagnostic criteria in conjunction with anti-PF4 and SRA testing is the gold standard of clinical diagnosis of HIT-II in aSAH patients.
AhmedIMajeedAPowellR. Heparin induced thrombocytopenia: diagnosis and management update. Postgrad Med J2007; 83: 575–582.
4.
WarkentinTEKeltonJG. A 14-year study of heparin-induced thrombocytopenia. Am J Med1996; 101: 502–507.
5.
GirolamiBGirolamiA. Heparin-induced thrombocytopenia: a review. Semin Thromb Hemost2006; 32: 803–809.
6.
HarbrechtUBastiansBKredteckA, et al.Heparin-induced thrombocytopenia in neurologic disease treated with unfractionated heparin. Neurology2004; 62: 657–659.
7.
KimGHHahnDKKellnerCP, et al.The incidence of heparin-induced thrombocytopenia type II in patients with subarachnoid hemorrhage treated with heparin versus enoxaparin. J Neurosurg2009; 110: 50–57.
8.
KhattarNKJamesRF. Heparin: the silver bullet of aneurysmal subarachnoid hemorrhage?Front Neurol2018; 9: 97. DOI:10.3389/fneur.2018.00097
9.
AlarajAWallaceAManderN, et al.Risk factors for heparin-induced thrombocytopenia type II in aneurysmal subarachnoid hemorrhage. Neurosurgery2011; 69: 1030–1036.
10.
HohBLAghiMPryorJC, et al.Heparin-induced thrombocytopenia type II in subarachnoid hemorrhage patients: incidence and complications. Neurosurgery2005; 57: 243–248.
11.
HaymanEGPatelAPJamesRF, et al.Heparin and heparin-derivatives in post-subarachnoid hemorrhage brain injury: a multimodal therapy for a multimodal disease. Molecules2017; 22(5): 724. DOI:10.3390/molecules22050724
12.
KunzMSillerSNellC, et al.Low-Dose versus therapeutic range intravenous unfractionated heparin prophylaxis in the treatment of patients with severe aneurysmal subarachnoid hemorrhage after aneurysm occlusion. World Neurosurg2018; 117: e705–e711.
13.
WarkentinTEKeltonJG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med.2001; 135: 502–506.
14.
CukerAGimottyPACrowtherMA, et al.Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood2012; 120: 4160–4167.
15.
BenkenSTTesoroEPKimKS, et al.Treatment outcomes of heparin-induced thrombocytopenia in subarachnoid hemorrhage patients: a 4-year, retrospective single-center review. Neurocrit Care2012; 17: 177–182.
16.
SellengKWarkentinTEGreinacherA. Heparin-induced thrombocytopenia in intensive care patients. Crit Care Med2007; 35: 1165–1176.
17.
SakrYHaetscherFGonsalvesMD, et al.Heparin-induced thrombocytopenia type II in a surgical intensive care unit. J Crit Care2012; 27: 232–241.
18.
WarkentinTEGreinacherA. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg.2003; 76: 2121–2131.
19.
SmytheMAKoerberJMMattsonJC. The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospital. Chest2007; 131: 1644–1649.
20.
PouplardCReginaSMayM-A, et al.Heparin-induced thrombocytopenia: a frequent complication after cardiac surgery. Arch Mal Coeur Vaiss2007; 100: 563–568.
21.
JunqueiraDRPeriniEPenholatiRR, et al.Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients. Cochrane Database Syst Rev2017, Issue 4. Art. No.: CD007557. DOI:10.1002/14651858.CD007557.pub3.
22.
ZwickerJIUhlLHuangW-Y, et al.Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost2004; 2: 2133–2137.
23.
PauznerRGreinacherASellengK, et al.False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Thromb Haemost2009; 7: 1070–1074.
24.
ChaturvediSKohliRMcCraeK. Over-testing for heparin induced thrombocytopenia in hospitalized patients. J Thromb Thrombolysis2015; 40: 12–16.
25.
OrtelTL. Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation. Hematology Am Soc Hematol Educ Program2009; 1: 225–232. DOI:10.1182/asheducation-2009.1.225
26.
LinkinsL-ADansALMooresLK, et al.Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines. CHEST2012; 141: e495S–e530S.
27.
LoGKJuhlDWarkentinTE, et al.Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost2006; 4: 759–765.
28.
CukerAArepallyGCrowtherMA, et al.The HIT expert probability (HEP) score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion. J Thromb Haemost2010; 8: 2642–2650.
29.
PishkoAMFardinSLeflerDS, et al.Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia. Blood Adv2018; 2: 3155–3162.
30.
BloomMBZawAAHoangDM, et al.Body mass index strongly impacts the diagnosis and incidence of heparin-induced thrombocytopenia in the surgical intensive care unit. J Trauma Acute Care Surg2016; 80: 398–403.. discussion 403-404.
31.
Trehel-TursisVLouvain-QuintardVZarroukiY, et al.Clinical and biologic features of patients suspected or confirmed to have heparin-induced thrombocytopenia in a cardiothoracic surgical ICU. Chest2012; 142: 837–844.
